Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-10-004633
Filing Date
2010-05-03
Accepted
2010-05-03 16:33:34
Documents
20
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2198073z10-q.htm 10-Q 545022
2 EXHIBIT 10.1 a2198073zex-10_1.htm EX-10.1 70831
3 EXHIBIT 10.2 a2198073zex-10_2.htm EX-10.2 57458
4 EXHIBIT 10.3 a2198073zex-10_3.htm EX-10.3 75472
5 EXHIBIT 10.4 a2198073zex-10_4.htm EX-10.4 63966
6 EXHIBIT 10.5 a2198073zex-10_5.htm EX-10.5 75193
7 EXHIBIT 10.6 a2198073zex-10_6.htm EX-10.6 59230
8 EXHIBIT 10.7 a2198073zex-10_7.htm EX-10.7 104659
9 EXHIBIT 31.1 a2198073zex-31_1.htm EX-31.1 7761
10 EXHIBIT 31.2 a2198073zex-31_2.htm EX-31.2 7781
11 EXHIBIT 32.1 a2198073zex-32_1.htm EX-32.1 4400
18 G52352KII001.JPG g52352kii001.jpg GRAPHIC 2562
19 G52352KMI001.JPG g52352kmi001.jpg GRAPHIC 2562
20 G52352KQI001.JPG g52352kqi001.jpg GRAPHIC 2562
  Complete submission text file 0001047469-10-004633.txt   2973364

Data Files

Seq Description Document Type Size
12 EX-101.INS vrtx-20100331.xml EX-101.INS 298379
13 EX-101.SCH vrtx-20100331.xsd EX-101.SCH 22896
14 EX-101.CAL vrtx-20100331_cal.xml EX-101.CAL 54929
15 EX-101.LAB vrtx-20100331_lab.xml EX-101.LAB 289128
16 EX-101.PRE vrtx-20100331_pre.xml EX-101.PRE 141400
17 EX-101.DEF vrtx-20100331_def.xml EX-101.DEF 19462
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 10793379
SIC: 2834 Pharmaceutical Preparations